HIV/AIDS Viremia
Low-level viremia not uncommon during very early period of primary HIV infection
Published in AIDS Weekly, July 25th, 2005
"Serial samples from source plasma donors with confirmed new HIV infection were investigated for low-level viremia (LLV) (i.e., <100 genome copies [cp]/mL) at time points preceding the period of steadily rising viremia above 100 cp/mL (ramp-up viremia).
"Fifteen of 44 plasma donor panels previously studied for the dynamics of HIV viremia during primary infection contained 70 samples with undetectable HIV-1 RNA by quantitative polymerase chain reaction (PCR)," scientists writing in the Journal of Acquired Immune Deficiency Syndromes report.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2005-07-25)
More Articles from AIDS Weekly
- HIV/AIDS Drug Use
Cocaine upregulates DC-SIGN expression on dendritic cells in HIV infection - HIV/AIDS Healthcare
Satellite pharmacy at HIV clinic improves physician-pharmacist interaction - HIV/AIDS Prevention
Branded advertising campaign increases condom use in Tanzania - HIV/Tuberculosis Coinfection
T cell decrease in HIV/TB coinfection leads to marked cytokine reduction - Allergy and Immunology
Patients coinfected with hepatitis C and HIV mount a full response to F protein - Anal Cancer
Chemoradiotherapy is feasible in anal carcinomas in HIV-positive patients - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
